BALCHEM CORP BCPC 87.8
Materials · NASDAQ · Data as of 2026-10-23
BALCHEM CORP (BCPC) has delivered +7.6% annualized revenue growth, +9.0% earnings growth, and +11.3% dividend growth over 10 years of data. Ranked #28 of 1968 stocks overall and #2 of 153 in the Materials sector by Steady Score.
About BALCHEM CORP
Company Overview
Balchem develops and manufactures specialty ingredients for human nutrition, food, pharmaceuticals, animal health, plant nutrition, sterilization and industrial uses. Its products include nutrients and delivery systems used in dietary supplements and foods, ingredients that support animal health and productivity, and specialty gases and chemicals for medical-device sterilization and other applications. The company sells to manufacturers and formulators through its own sales teams, distributors and agents.
Read more
Business Model & Revenue
Revenue comes from selling formulated ingredients, encapsulated nutrients, minerals, choline products, animal-feed additives, specialty gases and related products. Customer demand is tied to production volumes in food, supplements, pharmaceuticals, animal nutrition and industrial markets. Balchem operates manufacturing assets and earns from the value added through formulation, encapsulation and application expertise rather than from commodity distribution alone. Pricing, raw-material costs and product mix affect results.
Key Facts & Market Position
Balchem reports three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Human Nutrition and Health is the largest and covers food, beverage, supplement and pharmaceutical ingredients. Specialty Products includes performance gases used in sterilization and other regulated applications, giving the portfolio an industrial capability distinct from the nutrition businesses.